169 related items for PubMed ID: 7852747
1. Reduction of blood pressure and plasma triglycerides by omega-3 fatty acids in treated hypertensives.
Lungershausen YK, Abbey M, Nestel PJ, Howe PR.
J Hypertens; 1994 Sep; 12(9):1041-5. PubMed ID: 7852747
[Abstract] [Full Text] [Related]
2. Effects of a new fish oil concentrate on plasma lipids and lipoproteins in patients with hypertriglyceridaemia.
Mackness MI, Bhatnagar D, Durrington PN, Prais H, Haynes B, Morgan J, Borthwick L.
Eur J Clin Nutr; 1994 Dec; 48(12):859-65. PubMed ID: 7889894
[Abstract] [Full Text] [Related]
3. Short report: the effect of fish oil on blood pressure and high-density lipoprotein-cholesterol levels in phase I of the Trials of Hypertension Prevention.
Sacks FM, Hebert P, Appel LJ, Borhani NO, Applegate WB, Cohen JD, Cutler JA, Kirchner KA, Kuller LH, Roth KJ.
J Hypertens; 1994 Feb; 12(2):209-13. PubMed ID: 8021472
[Abstract] [Full Text] [Related]
4. Efficacy and safety of sibutramine for weight loss in obese patients with hypertension well controlled by beta-adrenergic blocking agents: a placebo-controlled, double-blind, randomised trial.
Sramek JJ, Leibowitz MT, Weinstein SP, Rowe ED, Mendel CM, Levy B, McMahon FG, Mullican WS, Toth PD, Cutler NR.
J Hum Hypertens; 2002 Jan; 16(1):13-9. PubMed ID: 11840225
[Abstract] [Full Text] [Related]
5. Effect of fish oil (n-3 polyunsaturated fatty acids) on plasma lipids, lipoproteins and inflammatory markers in HIV-infected patients treated with antiretroviral therapy: a randomized, double-blind, placebo-controlled study.
Thusgaard M, Christensen JH, Mørn B, Andersen TS, Vige R, Arildsen H, Schmidt EB, Nielsen H.
Scand J Infect Dis; 2009 Jan; 41(10):760-6. PubMed ID: 19685375
[Abstract] [Full Text] [Related]
6. Fish oil as an adjuvant in the treatment of hypertension.
Gray DR, Gozzip CG, Eastham JH, Kashyap ML.
Pharmacotherapy; 1996 Jan; 16(2):295-300. PubMed ID: 8820475
[Abstract] [Full Text] [Related]
7. Effects of omega-3 fatty acid supplementation on lipid levels in endstage renal disease patients.
Bowden RG, Jitomir J, Wilson RL, Gentile M.
J Ren Nutr; 2009 Jul; 19(4):259-66. PubMed ID: 19539180
[Abstract] [Full Text] [Related]
8. n -- 3 fatty acid supplementation during pregnancy in women with allergic disease: effects on blood pressure, and maternal and fetal lipids.
Barden AE, Dunstan JA, Beilin LJ, Prescott SL, Mori TA.
Clin Sci (Lond); 2006 Oct; 111(4):289-94. PubMed ID: 16822237
[Abstract] [Full Text] [Related]
9. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
Pessina AC, Ciccariello L, Perrone F, Stoico V, Gussoni G, Scotti A, Muggeo M.
Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914
[Abstract] [Full Text] [Related]
10. Effects of a fish oil supplement on blood pressure and serum lipids in patients treated for coronary artery disease.
Bairati I, Roy L, Meyer F.
Can J Cardiol; 1992 Mar; 8(1):41-6. PubMed ID: 1617510
[Abstract] [Full Text] [Related]
11. The effect of n-3 fatty acids on lipids and lipoproteins in patients treated with chronic haemodialysis: a randomized placebo-controlled intervention study.
Svensson M, Schmidt EB, Jørgensen KA, Christensen JH.
Nephrol Dial Transplant; 2008 Sep; 23(9):2918-24. PubMed ID: 18436564
[Abstract] [Full Text] [Related]
12. Effects of trans- and n-3 unsaturated fatty acids on cardiovascular risk markers in healthy males. An 8 weeks dietary intervention study.
Dyerberg J, Eskesen DC, Andersen PW, Astrup A, Buemann B, Christensen JH, Clausen P, Rasmussen BF, Schmidt EB, Tholstrup T, Toft E, Toubro S, Stender S.
Eur J Clin Nutr; 2004 Jul; 58(7):1062-70. PubMed ID: 15220949
[Abstract] [Full Text] [Related]
13. Concomitant use of policosanol and beta-blockers in older patients.
Castaño G, Mas R, Gámez R, Fernández J, Illnait J, Fernández L, Mendoza S, Mesa M, Gutiérrez JA, López E.
Int J Clin Pharmacol Res; 2004 Jul; 24(2-3):65-77. PubMed ID: 15689053
[Abstract] [Full Text] [Related]
14. The effects of low doses of n-3 fatty acid supplementation on blood pressure in hypertensive subjects. A randomized controlled trial.
Radack K, Deck C, Huster G.
Arch Intern Med; 1991 Jun; 151(6):1173-80. PubMed ID: 1828336
[Abstract] [Full Text] [Related]
15. Delayed omega-3 fatty acid supplements in renal transplantation. A double-blind, placebo-controlled study.
Bennett WM, Carpenter CB, Shapiro ME, Strom TB, Hefty D, Tillman M, Abrams J, Ryan D, Kelley VR.
Transplantation; 1995 Feb 15; 59(3):352-6. PubMed ID: 7871564
[Abstract] [Full Text] [Related]
16. Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial.
Freund-Levi Y, Eriksdotter-Jönhagen M, Cederholm T, Basun H, Faxén-Irving G, Garlind A, Vedin I, Vessby B, Wahlund LO, Palmblad J.
Arch Neurol; 2006 Oct 15; 63(10):1402-8. PubMed ID: 17030655
[Abstract] [Full Text] [Related]
17. Blood pressure reduction and antihypertensive medication use in the losartan intervention for endpoint reduction in hypertension (LIFE) study in patients with hypertension and left ventricular hypertrophy.
Devereux RB, de Faire U, Fyhrquist F, Harris KE, Ibsen H, Kjeldsen SE, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Wedel H, Hille DA, Dahlöf B.
Curr Med Res Opin; 2007 Feb 15; 23(2):259-70. PubMed ID: 17288679
[Abstract] [Full Text] [Related]
18. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.
Kim SH, Kim YD, Lim DS, Yoon MH, Ahn YK, On YK, Lee JW, Kim IJ, Park JB, Kim JJ, Chung WS, Yang JY, Seo HS, Shin EK, Kim HS, Korean Multicenter Amlodipine Study Investigators.
Clin Ther; 2007 Sep 15; 29(9):1924-36. PubMed ID: 18035192
[Abstract] [Full Text] [Related]
19. [Nebivolol, a third generation beta blocker: the modern treatment of hypertension. Results of a multicentric observational study].
von Fallois J, Faülhaber HD.
Fortschr Med Orig; 2000 Jul 27; 118 Suppl 2():77-82. PubMed ID: 15700490
[Abstract] [Full Text] [Related]
20. Effect of eicosapentaenoic and docosahexaenoic acids on blood pressure in hypertension. A population-based intervention trial from the Tromsø study.
Bønaa KH, Bjerve KS, Straume B, Gram IT, Thelle D.
N Engl J Med; 1990 Mar 22; 322(12):795-801. PubMed ID: 2137901
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
